Automated description from the Alliance of Genome Resources (Release 7.2.0)
Predicted to enable butyryl-CoA dehydrogenase activity; identical protein binding activity; and nucleotide binding activity. Predicted to be involved in butyrate catabolic process and fatty acid beta-oxidation using acyl-CoA dehydrogenase. Predicted to act upstream of or within fatty acid metabolic process. Located in mitochondrion. Is expressed in several structures, including heart; liver; lung; pancreas; and placenta. Used to study short chain acyl-CoA dehydrogenase deficiency. Human ortholog(s) of this gene implicated in alcohol use disorder and short chain acyl-CoA dehydrogenase deficiency. Orthologous to human ACADS (acyl-CoA dehydrogenase short chain).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.